Clinical Trials Logo

Clinical Trial Summary

In this study, we will evaluate the effectiveness of several doses of oral selenomethionine in raising biomarkers of selenium status including plasma selenium concentrations.


Clinical Trial Description

Results of studies with animal tumor models and human clinical trials suggest that the essential nutrient selenium can be anti-tumorigenic if consumed at levels greater than nutritional requirements. If it is possible to increase plasma selenium concentrations above 120 nanograms per milliliter with less than 200 micrograms of selenium daily, then it is possible that supplementation can be accomplished through the use of selenium-containing foods. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00803699
Study type Interventional
Source USDA Grand Forks Human Nutrition Research Center
Contact
Status Completed
Phase N/A
Start date November 2005
Completion date September 2007

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05489666 - Effects of Vitamin D on Skeletal Muscle Strength in Resistance Trained Adult Females N/A
Completed NCT03279315 - An Iodine Balance Experiment N/A
Recruiting NCT06074770 - Study on Dietary Intake Levels of Iodine for 3-6 Years Old Pre-school Children
Completed NCT00292812 - Clinical Effects of a Nucleotides-Supplemented Infant Formula N/A
Recruiting NCT04287816 - Achieving Nutritional Adequacy Of Vitamins E and K With An Egg/Plant-Based Food Pairing - Study 1 N/A
Active, not recruiting NCT04286321 - Achieving Nutritional Adequacy Of Vitamins E and K With An Egg/Plant-Based Food Pairing - Study 2 N/A
Completed NCT04419103 - Study on Physiologic Requirement and Dietary Recommended Nutrient Intake (RNI) of Iodine in Children
Recruiting NCT04492657 - Study on the Compensatory Mechanism of Iodine Nutrition and the Optimal Intake Level of Lactating Women
Not yet recruiting NCT05730803 - Displacement of Iodine Balance Value During Pregnancy and the Mechanism of Breast Iodine Homeostasis During Lactation